On December 1, 2025, Benitec Biopharma Inc. held its annual meeting where 85.06% of shares participated; all proposals, including director elections and executive compensation, were approved by stockholders. The meeting saw 22,327,761 shares represented and major votes included 22,150,169 for director Dr. Jerel Banks and 17,239,339 for executive compensation.